Diosgenin Inhibits Prostate Cancer Progression by Inducing UHRF1 Protein Degradation
Cited by 0
Related Papers
The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
|Cell Death and Disease|2017|128
PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2018|126